Evolutionary implications of Avian Infectious Bronchitis Virus (AIBV) analysis

Cell Research

Volumn 16, Issue 3, 2006, Pages 323-327

  Shi, Peng ^a,b   Yu, Li ^b   Fu, Yun Xin ^c   Huang, Jing Fei ^a   Zhang, Ke Qin ^b   Zhang, Ya Ping ^a,b  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b YUNNAN UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Adaptive evolution; Avian infectious Bronchitis Virus; Positive selection; SARS Coronavirus; Vaccine development

Indexed keywords

VIRUS VACCINE;

AMINO ACID SUBSTITUTION; ARTICLE; AVIAN INFECTIOUS BRONCHITIS VIRUS; EVOLUTION; GENETICS; SARS CORONAVIRUS; SYNTHESIS;

AMINO ACID SUBSTITUTION; EVOLUTION; INFECTIOUS BRONCHITIS VIRUS; SARS VIRUS; VIRAL VACCINES;

AVIAN INFECTIOUS BRONCHITIS VIRUS; SARS CORONAVIRUS;

EID: 33645083991     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/sj.cr.7310041     Document Type: Article

References (19)

1. th ed Iowa State University Press: Ames 1991:471-484.
2. Collisson EW, Parr RL, Wang L, Williams AK. An overview of the molecular characteristics of avian infectious bronchitis virus. Poult Sci Rev 1992; 4:41-55.
3. th ed Iowa State University Press: Ames 1997:511-526.
4. Cavanagh D, Davis PJ. Coronavirus IBV: removal of spike glycopolypeptide S1 by urea abolishes infectivity and haemagglutination but not attachment to cells. J Gen Virol 1986; 67:1443-1448.
5. Cavanagh D, Davis PJ, Mockett AP. Amino acids within hypervariable region 1 of avian coronavirus IBV (Massachusetts serotype) spike glycoprotein are associated with neutralization epitopes. Virus Res 1988; 11:141-150.
6. Lee CW, Jackwood MW. Origin and evolution of Georgia 98 (GA98), a new serotype of avian infectious bronchitis virus. Virus Res 2001; 80:33-39.
7. Pei J, Briles WE, Collisson EW. Memory T cells protect chicks from acute infectious bronchitis virus infection. Virology 2003; 306:376-384.
8. Chinese SMEC. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 2004; 303:1666-1669.
9. Song HD, Tu CC, Zhang GW, et al. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc Natl Acad Sci U S A 2005; 102:2430-2435.
10. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994; 22:4673-4680.
11. Kumar S, Tamura K, Jakobsen IB, Nei M. MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 2001; 17:1244-1245.
12. Felsenstein. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 1985; 39:783-791.
13. Yang Z, Nielsen R, Goldman N, Pedersen AM. Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 2000; 155:431-449.
14. Yang Z. PAML: a program package for phylogenetic analysis by maximum likelihood. Comput Appl Biosci 1997; 13:555-556.
15. Karaca K, Naqi S, Gelb J Jr. Production and characterization of monoclonal antibodies to three infectious bronchitis virus serotypes. Avian Dis 1992; 36:903-915.
16. Hopp TP, Woods KR. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A 1981; 78:3824-3828.
17. Guan Y, Zheng BJ, He YQ, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 2003; 302:276-278.
18. Wong SK, Li W, Moore MJ, Choe H, Farzan M. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J Biol Chem 2004; 279:3197-3201.
19. Fitch WM, Bush RM, Bender CA, Cox NJ. Long term trends in the evolution of H(3) HA1 human influenza type A. Proc Natl Acad Sci U S A 1997; 94:7712-7718.